Anaesthesia and cancer: can anaesthetic drugs modify gene expression?
- PMID: 32863874
- PMCID: PMC7434501
- DOI: 10.3332/ecancer.2020.1080
Anaesthesia and cancer: can anaesthetic drugs modify gene expression?
Abstract
Cancer remains a primary cause of morbidity and mortality worldwide, and its incidence continues to increase. The most common cause of death in cancer patients is tumour recurrence. Surgery is the gold standard in the treatment of most tumours. However, cancer surgery can lead to the release of tumour cells into the systemic circulation. Surgical stress and several perioperative factors have been suggested to boost tumour growth, thereby increasing the risk of metastatic recurrence. Preclinical and clinical studies suggest that anaesthetics and adjuvants administered during the perioperative period may impact cancer recurrence and survival. This document summarises the current evidence regarding the effects of anaesthetic drugs and analgesic techniques on the immune system, systemic inflammatory response and tumour cells, as well as their impact on cancer recurrence.
Keywords: NSAIDs; anaesthesia; anaesthetics; analgesia; cancer recurrence; metastases; opioid; regional anaesthesia.
© the authors; licensee ecancermedicalscience.
References
-
- Gupta K, Kshirsagar S, Chang L, et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res. 2002;62:4491–4498. - PubMed